ACSL3 and melanoma: This ACSL3-dependent anti-ferroptotic mechanism may be active in vivo and contribute to metastasis: ACSL3 activity promotes the survival of metastatic melanoma cells that transit through the lymph fluid where they are exposed to a MUFA-rich environment [112].